Canada Markets open in 8 hrs 46 mins

Adastra Holdings Ltd. (XTXXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.91650.0000 (0.00%)
At close: 11:30AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.9165
Open0.9165
BidN/A x N/A
AskN/A x N/A
Day's Range0.9165 - 0.9165
52 Week Range0.7430 - 1.1688
Volume2
Avg. Volume30
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

    VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

  • CNW Group

    Adastra Holdings Reports Record Third Quarter Results

    Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") has today filed its consolidated financial statements and related management discussion and analysis for the three and nine months ended September 30, 2021, and 2020, both of which are available at www.sedar.com.

  • CNW Group

    Adastra Holdings Provides Product Growth Update and Announces Insider Open-Market Stock Purchases

    Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") today announced positive operational and financial developments as the Company continues to pursue its mission to be a leader in the development and manufacture of pharma-quality, cannabis API and derivative products. These developments include record shipments in September, product portfolio expansion, and continued progress with Health Canada regarding its Controlled Substances Dealers